Cargando…
A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection
Resectable pancreatic adenocarcinoma (PC) is generally managed with surgery followed by chemotherapy, but the role of postoperative chemoradiation (pCRT) is controversial. We sought to identify a microRNA (miRNA) expression profile associated with higher risk for local-regional recurrence (LRR), whi...
Autores principales: | Wolfe, Adam R., Wald, Patrick, Webb, Amy, Sebastian, Nikhil, Walston, Steve, Robb, Ryan, Chen, Wei, Vedaie, Marall, Dillhoff, Mary, Frankel, Wendy L., Kwon, Wooil, Jang, Jin-Young, Williams, Terence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075466/ https://www.ncbi.nlm.nih.gov/pubmed/32206188 http://dx.doi.org/10.18632/oncotarget.27496 |
Ejemplares similares
-
Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma
por: Sebastian, Nikhil T., et al.
Publicado: (2021) -
MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma
por: Pettit, Cory, et al.
Publicado: (2018) -
Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection
por: Wolfe, Adam R., et al.
Publicado: (2020) -
Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature
por: Wald, Patrick, et al.
Publicado: (2017) -
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
por: Wu, Chao, et al.
Publicado: (2020)